- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
MR maverick dodges Nasdaq bullet
Other headlinesAccelaRAD extends client baseCarestream readies laser imager
MR maverick dodges Nasdaq bullet
Fonar has until Oct. 5 to prove to the Nasdaq exchange that the company has at least $500,000 in net income for the fiscal year ending June 30, 2009. The deadline was set by Nasdaq Listing and Hearing Review Council, which determined on June 24 that the maker of MR scanners can remain listed on the exchange until that time. Fonar has reported net income of more than $1 million for the first nine months of the current fiscal year.
AccelaRAD extends client base
IT network specialist AccelaRAD announced June 26 the installation of advanced digital management software at five new sites. Three are Mid-Atlantic Unified Health System-affiliated imaging centers, which are using AccelaRAD’s Virtual Radiology Network to provide PACS functionality, offsite archiving, and sophisticated online communication with referring physicians. The other two are using the network to provide remote access to images for offsite radiology reading groups.
Carestream readies laser imager
The FDA has cleared a tabletop laser imager from Carestream Health designed for digital mammography and general radiography. Shipments in the U.S. and other countries are set to begin immediately. The new laser imager, dubbed DRYVIEW 5850, offers 508 pixels-per-inch output. Two on-line film trays support DICOM printing of general radiography and mammography from both full-field digital and computed radiography systems.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
